Essex Financial Services’s NovoCure NVCR Stock Holding History

Essex Financial Services’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,407	Closed	-$282K	–	511
2022 Q1	$282K	Buy	3,407 +107	+3%	+$7.88K	0.03%	395
2021 Q4	$248K	Hold	3,300	–	–	0.02%	410
2021 Q3	$383K	Buy	3,300 +325	+11%	+$49.1K	0.04%	305
2021 Q2	$393K	Hold	2,975	–	–	0.06%	269
2021 Q1	$393K	Sell	2,975 -625	-17%	-$98.9K	0.07%	220
2020 Q4	$623K	Buy	3,600 +175	+5%	+$23.9K	0.12%	165
2020 Q3	$381K	Sell	3,425 -525	-13%	-$42K	0.09%	192
2020 Q2	$234K	Sell	3,950 -2,400	-38%	-$158K	0.07%	223
2020 Q1	$428K	Hold	6,350	–	–	0.15%	140
2019 Q4	$535K	Buy	+6,350	New	+$513K	0.15%	141

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Essex Financial Services's NVCR Position: Q2 2022 in Review

Essex Financial Services sold out of NovoCure (NVCR) in Q2 2022, closing a stake of 3,407 shares — an estimated $282K sold.

Essex Financial Services first reported a position in NVCR in Q4 2019 and held it in 10 quarters. The position peaked at $623K in Q4 2020. 316 funds tracked by Wall St. Rank hold NVCR as of Q2 2022.

Essex Financial Services reported no remaining NovoCure position as of Q2 2022 after selling out during the quarter.
Essex Financial Services sold 3,407 NovoCure shares in Q2 2022, an estimated $282K.
Essex Financial Services first reported a position in NovoCure in Q4 2019 and held it in 10 quarters.
Essex Financial Services's NovoCure position peaked at $623K in Q4 2020.
316 funds tracked by Wall St. Rank held NovoCure as of Q2 2022.

Based on Essex Financial Services's 13F filing for Q2 2022, filed 1 Aug 2022.